Literature DB >> 30057284

Significant circulation of influenza B viruses mismatching the recommended vaccine-lineage in South Korea, 2007-2014.

Ji Yun Noh1, Won Suk Choi1, Joon Young Song1, Han Sol Lee2, Sooyeon Lim2, Jacob Lee3, Yu Bin Seo3, Jin-Soo Lee4, Seong-Heon Wie5, Hye Won Jeong6, Jung Yeon Heo6, Young Keun Kim7, Kyung Hwa Park8, Shin Woo Kim9, Sun Hee Lee10, Jung Hwa Lee11, Dong Hyun Kim12, Sung Il Woo13, Chae Seung Lim14, Kyung Soon Cho15, Hee Jin Cheong1, Woo Joo Kim16.   

Abstract

We aimed to characterize the lineages of influenza B viruses obtained from clinical specimens during the 2007-2014 seasons in South Korea. RT-PCR for the partial hemagglutinin gene of influenza B virus was performed on laboratory-confirmed influenza B samples from the 2007-2008 season to 2013-2014 season. A phylogenetic tree was generated, and current influenza vaccine strains for the Northern Hemisphere were used as representative strains of Victoria and Yamagata lineages. A total of 571 influenza B virus sequences were analyzed. During the 2009-2010 season, most of the circulating influenza B viruses matched the vaccine strain; 91.0% (91/100) of viruses belonged to the Victoria lineage. In the 2007-2008, 2011-2012, and 2013-2014 seasons, co-circulation of each influenza B lineage was found with a match ratio to the vaccine strain of 53.2% (42/79), 40.9% (63/154), and 58.3% (134/230), respectively. Overall, 41.7% (238/571) of the circulating influenza B viruses belonged to the lineage mismatching the vaccine strain. During the seven influenza seasons, influenza B epidemics were substantial in four seasons in South Korea. Significant mismatches of the vaccine and lineage of the circulating influenza B viruses were found. The current trivalent influenza vaccine may not be fully suitable for effective protection against influenza B.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Epidemiology; Influenza B virus

Mesh:

Substances:

Year:  2018        PMID: 30057284     DOI: 10.1016/j.vaccine.2018.07.021

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

Review 1.  Reverse genetics for influenza B viruses and recent advances in vaccine development.

Authors:  Stivalis Cardenas-Garcia; C Joaquin Caceres; Daniela Rajao; Daniel R Perez
Journal:  Curr Opin Virol       Date:  2020-11-27       Impact factor: 7.090

2.  Association of Consecutive Influenza Vaccinations and Pneumonia: A Population-Based Case-Control Study.

Authors:  Liang-Tsai Yeh; Chi-Ho Chan; Shun-Fa Yang; Han-Wei Yeh; Ying-Tung Yeh; Yu-Hsun Wang; Ming-Chih Chou; Chao-Bin Yeh; Ying-Hock Teng
Journal:  Int J Environ Res Public Health       Date:  2019-03-26       Impact factor: 3.390

3.  Increasing serum antibodies against type B influenza virus in 2017-2018 winter in Beijing, China.

Authors:  Yao Yao; Lingling Chen; Dong Zhu; Runqing Li; Zhipeng Zhao; Wenqi Song; Xiuying Zhao; Kun Qin
Journal:  AMB Express       Date:  2022-10-01       Impact factor: 4.126

4.  Clinical similarities between influenza A and B in children: a single-center study, 2017/18 season, Korea.

Authors:  Yu Na Oh; San Kim; Young Bae Choi; Sung Il Woo; Youn-Soo Hahn; Joon Kee Lee
Journal:  BMC Pediatr       Date:  2019-12-03       Impact factor: 2.125

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.